Home › Funds › Opaleye Management Inc. › EWTX
Opaleye Management Inc. position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Opaleye Management Inc. reported holding 500,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$20.3M, representing 1.84% of its reported portfolio and ranking #15 among its reported holdings. Opaleye Management Inc. has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s EWTX position evolved
Opaleye Management Inc. first disclosed a stake in EWTX in Q3 2023 at 875,405 shares (US$5.0M). The position peaked in Q2 2026 at 500,000 shares, worth US$20.3M. Across 12 filings, Opaleye Management Inc. increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 500,000 shares valued at US$20.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 875.40K | $5.02M | New |
| Q4 2023 | 699.00K | $7.65M | Reduce |
| Q1 2024 | 665.00K | $12.13M | Reduce |
| Q2 2024 | 580.00K | $10.45M | Reduce |
| Q3 2024 | 522.50K | $13.95M | Reduce |
| Q4 2024 | 480.00K | $12.82M | Reduce |
| Q1 2025 | 395.00K | $8.69M | Reduce |
| Q2 2025 | 490.00K | $6.42M | Add |
| Q3 2025 | 500.00K | $8.11M | Add |
| Q4 2025 | 500.00K | $12.41M | Hold |
| Q1 2026 | 500.00K | $15.75M | Hold |
| Q2 2026 | 500.00K | $20.32M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M sh · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held EWTX?
Opaleye Management Inc. has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Opaleye Management Inc.'s current position in EWTX?
As of Q2 2026, Opaleye Management Inc. holds 500.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $20.32M, representing 1.84% of its reported portfolio and ranking #15.
Has Opaleye Management Inc. been buying or selling EWTX?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in EWTX. The position peaked in Q2 2026 at 500.00K shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.